Oncology
Symposium
The stage I non-small-cell lung cancer
Clinical
What a pulmonologist and thoracic surgeon should know
Aims : This session aims to provide a comprehensive and updated overview of issues related to early stage lung cancer that are still being debated. These issues include the optimal diagnostics, the benefits of molecular diagnostics and biomarkers, the factors that influence the treatment outcome, and the rapidly changing spectrum of surgical options for stage I NSCLC.
Target audience :
Oncologist, Pulmonologist, Radiologist, Thoracic surgeon
10:45
Biological markers
V. Westeel(Besançon, France)
COI
1
4925
11:15
Role of CT and PET in detecting non-aggressive stage IA NSCLC
W. De Wever(Leuven, Belgium)
COI
2
4926
11:45
Wide therapeutic spectrum for limited disease: lobectomy vs. segmentectomy, and video-assisted thoracoscopic surgery (VATS) vs. open surgery
M. Hürtgen(Koblenz, Germany)
COI
3
4927
12:15
Survival predictors
P. Van Schil(Edegem (Antwerp), Belgium)
COI
4
4928
. . .
